News About: Pharm. Industry
US FDA approves first clinical trial using embryonic stem cells
Cha Bio & Diostech, a local biopharmaceutical company, said on November 24 that the US based Advanced Cell Technology, Inc. (ACT), Cha’s joint research collaborator, received from the US Food and Drug Administration a...
Pharmacists group seeking to overhaul small package system
The Korean Pharmaceutical Association is making all-out efforts to overhaul the controversial small package system to make it “better” for both manufacturers and pharmacists.
Under the current regulation, drug make...
SK Chemicals to set out flu vaccine production plan
In a move to contain pandemic flu fears, SK Chemicals plans to construct its large-scale influenza vaccine plant in Andong of North Chungcheong Province, which will be fully backed by the government and provincial bod...
Lim’s resignation sparks debate over local CEO’s authority
The sudden resignation of Hanmi Pharmaceutical President Lim Sun-min has sparked a debate in industry.
He seemingly decided to step down to take responsibilities for poor sales this year, but many say the timing is...
Kwandong, Salvat ink agreement over OAB medicine
Kwangdong Pharmaceutical said on November 16 that it has signed a licensing agreement with Spain based Laboratorios SALVAT, S.A. (Salvat), granting the former the rights to develop, register and market Tarafenacin in ...
Hanmi President to step down
Lim Sun-min, President of Hanmi Pharmaceutical, offered to resign over poor sales this year, said a company official.
Lim expressed his resignation to all executives in a meeting on November 15.
Hanmi has yet to...
Daewoong to announce positive results for DWP05195, chronic intractable painkiller
Daewoong Pharmaceutical says it has completed Phase 1 local clinical study of DWP05195, neuropathic painkiller, in 120 healthy volunteers with neuropathy.
"We are extremely pleased with the results of this 120 heal...
Pharmaceutical industry sees transition
The Korean pharmaceutical industry is undergoing a major change as tightening regulations and uphill competition threatens to reshuffle the leader board of drug manufacturers.
Dong-A Pharml kept its number 1 rankin...
KPMA lukewarm over two-way sanctions
Starting on Nov. 28, the government will step up its fight against chronic illegal rebate practices whereby doctors and pharmacists receive money from drug makers in return for prescribing or recommending their produc...
Ilyang develops new influenza antiviral drug
Ilyang Pharm said it has filed a patent application for new antiviral agent, which could be used to both prevent and reduce the duration of fever and other symptoms associated with the influenza.
The mechanism of t...
